Background: This study investigates the feasibility and effectiveness of time-limited treatment protocols based upon cognitive and behavioural interventions. Method: Seventeen patients with DSM-IV diagnoses of hypochondriasis were offered 12 1-hour sessions of either ‘pure’ cognitive or ‘pure’ behavioural (i.e. exposure in vivo and response prevention) treatment. Patients were used as their own controls by observing a 4-week period without interventions before and after treatment. Results: Patients in both treatment conditions improved on specific measures of hypochondriasis (Kellner’s Illness Attitude Scales) and depression. These changes took place during the active treatment period, whereas in the control periods scores remained unchanged. Furthermore, no differential treatment effectiveness could be demonstrated. Conclusions: Cognitive and behavioural interventions seem to be active ingredients in the treatment of hypochondriasis, although the contribution of nonspecific factors (e.g. patient motivation, therapist attitudes, and the therapeutic relationship) requires further study.

Keywords:
Hypochondriasis, Cognitive therapy, Behaviour therapy, Exposure, Treatment outcome
1.
Fallon BA, Klein BW, Liebowitz MR: Hypochondriasis: Treatment strategies. Psychiatr Ann 1993;23:374–381.
2.
Kellner RJ: Somatization and Hypochondriasis. New York, Praeger, 1986.
3.
Kellner R: Prognosis of treated hypochondriasis. A clinical study. Acta Pychiatr Scand 1983;67:69–79.
4.
Fava GA, Freyberger HJ, Bech P, Christodoulou G, Sensky T, Theorell T, Wise TN: Diagnostic criteria for use in psychosomatic research. Psychother Psychosom 1995;63:1–8.
5.
Beck AT, Emery G: Anxiety Disorders and Phobias: A Cognitive Perspective. New York, Basic Books, 1985.
6.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, APA, 1994.
7.
Warwick HMC, Salkovskis PM: Hypochondriasis. Behav Res Ther 1990;28:105–117.
8.
Kellner R: Diagnosis and treatment of hypochondriacal syndromes. Psychosomatics 1992;33:278–289.
9.
Floru L: Verhaltenstherapeutische Versuche durch systematische Desensibilisierung. Psychiatr Clin 1973;6:300–318.
10.
Rifkin BG: The treatment of cardiac neurosis using systematic desensitization. Behav Res Ther 1968;6:239–240.
11.
Kumar K, Wilkinson JCM: Thought stopping: A useful technique in phobias of internal stimuli. Br J Psychiatry 1971;119:305–307.
12.
Furst JB, Cooper A: Combined use of imaginal and interoceptive stimuli in desensitizing fear of heart attacks. J Behav Ther Exp Psychiatry 1970;1:57–61.
13.
O’Donnell JM: Implosive therapy with hypnosis in the treatment of cancer phobia: A case report. Psychother Theory Res Pract 1978;15:181–183.
14.
Johansson J, Öst L-G: Applied relaxation in treatment of ‘cardiac neurosis’: A systematic case study. Psychol Rep 1981;48:463–468.
15.
Reinders M: De behandeling van een patient met hypochondrische klachten. Gedragstherapie 1988;21:45–55.
16.
Warwick HMC, Marks IM: Behavioural treatment of illness phobia and hypochondriasis. Br J Psychiatry 1988;152:239–241.
17.
Feigenbaum W: Longterm efficacy of exposure in vivo for cardiac phobia; in Hand I, Wittchen H-U (eds): Panic and Phobias. Heidelberg, Springer, 1986, pp 81–89.
18.
Nutzinger DO, Cayiroglu S, Grünberger J, Kieffer W, Zapotocky HG: Prognosis of cardiac phobia. Psychopathology 1990;23:63–72.
19.
Warwick HMC, Clark DM, Cobb AM, Salkovskis PM: A controlled trial of cognitive-behavioural treatment of hypochondriasis. Br J Psychiatry 1996;169:189–195.
20.
Miller D, Acton TMG, Hedge B: The worried well: their identification and management. J R Coll Physicians Lond 1988;22:158–165.
21.
Pérez Solera A: Tratamiento de trastornos hipochondriacos mediante un cambio de atribución. Anál Modif Conducta 1992;18:279–290.
22.
Salkovskis PM, Warwick HMC: Morbid preoccupations, health anxiety and reassurance: A cognitive-behavioural approach to hypochondriasis. Behav Res Ther 1986;24:597–602.
23.
Visser S, Bouman TK: Cognitive behavioural approaches in the treatment of hypochondriasis: Six single case cross-over studies. Behav Res Ther 1992;30:301–306.
24.
Barsky AJ, Geringer E, Wool CA: A cognitive educational treatment for hypochondriasis. Gen Hosp Psychiatry 1988;10:322–327.
25.
Avia MD, Ruiz MA, Olivares ME, Crespo M, Guisado AB, Sánchez A, Varela A: The meaning of psychological symptoms: Effectiveness of a group intervention with hypochondriacal patients. Behav Res Ther 1996;34:23–31.
26.
Stern R, Fernandez M: Group cognitive and behavioural treatment for hypochondriasis. Br Med J 1991;303:1229–1231.
27.
Salkovskis PM, Clark DM: Panic disorder and hypochondriasis. Adv Behav Res Ther 1993;15:23–48.
28.
Kellner RJ: Abridged Manual of the Illness Attitude Scales. Albuquerque, Department of Psychiatry, 1987.
29.
Rachman S, Hodgson R: Obsessional-compulsive complaints. Behav Res Ther 1977;15:389–395.
30.
Beck AT, Rush AJ, Shaw BF, Emery G: Cognitive Therapy of Depression. Chichester, Wiley, 1979.
31.
Bouman TK, Luteijn F, Albersnagel FA, van der Ploeg F: Enige ervaringen met de Beck Depression Inventory (BDI). Gedrag 1985;13:13–21.
32.
Arrindell WA, Ettema JHM: SCL-90, Handleiding bij een multidimensionele psychopathologie indicator. Lisse, Swets & Zeitlinger, 1986.
33.
Luteijn F, Starren JH, van Dijk H: Herziene handleiding NPV. Lisse, Swets & Zeitlinger, 1985.
34.
Haenen M-A, Schmidt AJM, Kroeze S, van den Hout MA: Hypochondriasis and symptom reporting – the effects of attention versus distraction. Psychother Psychosom 1996;65:43–48.
35.
Haenen M-A, Schmidt AJM, Schoenmakers M, van den Hout MA: Tactual sensitivity in hypochondriasis. Psychother Psychosom 1997;66:128–132.
36.
Warwick HMC: Assessment of hypochondriasis. Behav Res Ther 1995;33:845–853.
37.
Ferguson E, Daniel E: The Illness Attitude Scales (IAS): Psychometric evaluation in a non-clinical population. Pers Individ Diff 1995;18:463–469.
38.
Speckens AEM, Spinhoven P, Sloekers PPA, Bolk JH, van Hemert AM: A validation study of the Whitley Index, the Illness Attitude Scales and the Somatosensory Amplification Scale in general medical and general practice patients. J Psychosom Res 1995;40:95–104.
1998
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.